Therma Bright's Venowave Set for Major Growth with New HCPCS Code Approval
Therma Bright's Venowave secures new HCPCS code approval, paving the way for major growth and access to treatment for millions of patients in the United States.
The approval of the new HCPCS code for Venowave is crucial as it eliminates friction in payments and hesitancy by prescribing parties, opening up a potentially huge market in the United States. Patients with Chronic Venous Insufficiency and those in need of DVT prevention will now have access to Venowave without incurring out-of-pocket costs, impacting the lives of millions of individuals.
